Skip to Content

Dymista Approval History

  • FDA approved: Yes (First approved May 1st, 2012)
  • Brand name: Dymista
  • Generic name: azelastine and fluticasone
  • Dosage form: Nasal Spray
  • Company: Meda Pharmaceuticals, Inc.
  • Treatment for: Allergic Rhinitis

Dymista (azelastine and fluticasone) nasal spray is an H1-receptor antagonist and corticosteroid combination indicated for the relief of symptoms of seasonal allergic rhinitis.

Development History and FDA Approval Process for Dymista

May  2, 2012Approval MEDA Announces Dymista Approved by the FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.